Alternatives to Fluxergy

Developing advanced molecular and immunoassay diagnostic solutions for point-of-care testing.

Shift Labs develops advanced medical devices for point-of-care diagnostics and treatment.

Femasys is a biomedical company developing minimally invasive, in-office technologies for women's reproductive health, including fertility and permanent birth control solutions.

Sight Diagnostics develops rapid, accurate, and convenient diagnostic testing solutions, including a complete blood count analyzer.

Visby Medical develops and manufactures instrument-free, PCR-quality rapid diagnostic tests for infectious diseases at the point of care.

Develops in-vitro diagnostic platforms for rapid antimicrobial susceptibility testing.

Develops a proprietary, stand-alone platform for rapid, lab-grade molecular diagnostics at the point of need.

Develops a brain-computer interface for treating epilepsy.

Develops intravascular lithotripsy technology for treating calcified cardiovascular lesions.

Medical device company developing and commercializing clot removal devices for venous diseases.

AI-powered EEG device for rapid seizure detection in critical care.

Develops an AI-driven surgical navigation platform using 3D ultrasound for enhanced cancer treatment.

Cue is a health technology company developing and manufacturing a molecular diagnostic platform for rapid, lab-quality health testing at home.

Develops and commercializes minimally invasive robotic platforms for the neuroscience field.

Develops a minimally invasive implantable device for treating type 2 diabetes and obesity.

Global healthcare and homecare partner providing medical devices, products, and innovative solutions.

Developing minimally invasive water vapor ablation therapy to treat prostate, kidney, and bladder cancer.

CairnSurgical is developing the Breast Cancer Locator™ System to improve breast-conserving surgery by enhancing tumor localization and tissue inspection.

Leveraging the adaptive immune system to diagnose and treat disease.

Develops innovative surgical technology to make bone surgery safer and more precise by protecting soft tissues.

Global life sciences company providing diagnostic and biopharma laboratory services.

Medical technology company developing anesthesia-free kidney stone treatment.

Pioneering bio-engineered skin grafts for severe burns and chronic wounds.

Remote-controlled micro-robots for precise treatment of central nervous system disorders.

Develops advanced wound care solutions utilizing proprietary bio-active materials.

MeMed develops and commercializes host immune response diagnostic solutions to address complex clinical dilemmas and improve patient outcomes.

Global supplier of life science research tools, including antibodies, reagents, and assays.

Freenome is a biotechnology company developing a multi-cancer early detection blood test using machine learning and biology.

Biopharmaceutical company developing novel small-molecule therapeutics for rare kidney diseases, particularly Autosomal Dominant Polycystic Kidney Disease (ADPKD).

Develops innovative solutions for improved enteral feeding access and delivery.

FIZE Medical is developing a novel, non-invasive device for early detection of neurological diseases.

Developing novel immunotherapies and diagnostics for cancer.

AI-powered respiratory diagnosis for faster and more accessible lung disease testing.

DNA Medtech develops advanced diagnostic tools for personalized medicine and disease detection.

Firefly Neuroscience provides objective brain function assessments for mental illness using FDA-cleared Brain Network Analytics (BNA™) technology.

Organox develops and commercializes medical devices for organ preservation and assessment, aiming to improve outcomes for transplant patients.

Harnessing genetic data for digital insights in rare and germline disorders.

Personalized medicine startup focused on accurate cancer treatment through advanced diagnostics and functional drug sensitivity testing.

AI-powered blood test for early cancer detection and subtyping.

HealthCubed provides portable, AI-powered point-of-care diagnostic devices to improve healthcare access in remote areas.

Developing a liquid biopsy blood test for early disease detection and monitoring using epigenetic information.

Clinical-stage biopharmaceutical company developing next-generation therapies for obesity and cardiometabolic diseases.

AI-powered breast cancer detection and risk assessment solutions.

Revolutionizing genomic analysis with innovative sequencing technology.

Pioneering vision restoration therapies for severe retinal degenerations.

Developing ultrasound-mediated nonviral genetic medicines.

Scent-based multi-cancer early detection screening test using AI and bio-detectors.

Biotech startup developing laser bioprinting systems for regenerative medicine and biosensor applications.

Developing a new generation of molecular diagnostics for at-home use, combining laboratory accuracy with rapid test simplicity.

AI-powered diagnostic platform detecting and interpreting inaccessible body infra-sounds for enhanced medical diagnosis.

Develops advanced ultrasound imaging technology for medical diagnostics and research.

Eyebot is a startup developing AI-powered robotic solutions for automated eye care and vision testing.

Biopharmaceutical company developing innovative punctal plug technology for eye disease therapies.

Developing novel diagnostics to predict patient response to immunotherapy.

Developing bionic eye implants to restore vision for the blind.

Developing autonomous robotic phlebotomy devices to standardize blood collection and improve patient care.

Portable, affordable, AI-powered hematology lab for instant blood test results.

Developing advanced diagnostic technology to expand global access to healthcare.